Negative Pressure Wound Therapy (NPWT) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: September 19, 2023 Report Code: GDME1616EPD-ST

Select Item

Negative Pressure Wound Therapy (NPWT) Pipeline Market Report Overview

Negative Pressure Wound Therapy (NPWT) is used to treat acute and chronic wounds. A vacuum source of an NPWT device creates continuous or intermittent negative pressure inside the wound to remove fluid, exudates, and infectious materials which helps in healing and closure. The Negative Pressure Wound Therapy (NPWT) pipeline market research report provides comprehensive information about the NPWT pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·       NPWT Devices

·       Disposable NPWT Devices

·       NPWT Devices & Accessories

·       NPWT Dressings

·       Portable NPWT Devices
Key Territories ·       The US

·       Europe

·       India

·       New Zealand
Key Regulatory Paths ·       510(k)

·       CE

·       ICAC

·       TGA

·       de novo
Leading Companies ·       Aatru Medical LLC

·       Acelity L.P. Inc.

·       Adept Medical Ltd

·       Aroa Biosurgery Ltd

·       Ceramatec Inc

·       CloSure Inc

·       ConvaTec Group Plc

·       DeRoyal Industries Inc

·       Healyx Labs Inc

·       Invacare Corporation
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

NPWT Pipeline Market by Segments

The key segments in the NPWT pipeline market are NPWT devices, disposable NPWT devices, NPWT devices and accessories, NPWT dressings, and portable NPWT devices. As of September 2023, NPWT devices have the highest number of pipeline products.

NPWT Pipeline Market Analysis by Segments, 2023 (%)

NPWT Pipeline Market Analysis by Segments, 2023 (%)

Buy Full Report for More Segment Insights into the NPWT Pipeline Market

Download A Free Report Sample

NPWT Pipeline Market Segmentation by Territories

Some of the key territories in the NPWT market are the US, Europe, India, and New Zealand. As of September 2023, the US has the highest number of pipeline products.

NPWT Pipeline Market Analysis by Territories, 2023 (%)

NPWT Pipeline Market Analysis by Territories, 2023 (%)

Buy Full Report for More Territory Insights into the NPWT Pipeline Market

Download A Free Report Sample

NPWT Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the NPWT pipeline market are 510(k), CE, ICAC, TGA, and de novo. As of September 2023, 510(k) is the most followed pathway for pipeline products in the market.

NPWT Pipeline Market Analysis by Regulatory Paths, 2023 (%)

NPWT Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy Full Report for More Regulatory Path Insights into the NPWT Pipeline Market

Download A Free Report Sample

NPWT Pipeline Market – Competitive Landscape

Some of the key companies in the NPWT pipeline market are Aatru Medical LLC, Acelity L.P. Inc., Adept Medical Ltd, Aroa Biosurgery Ltd, Ceramatec Inc, CloSure Inc, ConvaTec Group Plc, DeRoyal Industries Inc, Healyx Labs Inc, and Invacare Corporation.

Aatru Medical LLC: It is a medical device company that specializes in technology development in negative pressure wound therapy for surgical incisions and chronic wounds. Aatru is headquartered in Cleveland, Ohio, the US.

Acelity L.P. Inc.: It is an advanced wound care company that, through its subsidiaries, develops and commercializes medical devices in the areas of wound management, plastic and reconstructive surgery, incision management, epidermal harvesting, and animal health. The company’s operations are spread across North America, Australasia, Europe, the Americas and East Asia. Acelity is headquartered in San Antonio, Texas, the US.

NPWT Pipeline Market Analysis by Companies, 2023

NPWT Pipeline Market Analysis by Companies, 2023

Buy Full Report for More Company Insights into the NPWT Pipeline Market

Download A Free Report Sample

Segments Covered in the Report

NPWT Pipeline Market Segments Outlook

  • NPWT Devices
  • Disposable NPWT Devices
  • NPWT Devices & Accessories
  • NPWT Dressings
  • Portable NPWT Devices

NPWT Pipeline Market Territories Outlook

  • The US
  • Europe
  • India
  • New Zealand

NPWT Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • ICAC
  • TGA
  • de novo

Scope

This report provides:

  • Extensive coverage of the Negative Pressure Wound Therapy (NPWT) under development.

  • Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.

  • Reviews of major players involved in the pipeline product development.

  • Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Negative Pressure Wound Therapy (NPWT) pipeline products.

  • Review of recent developments in the segment/industry.

Reasons to Buy

This report provides:

  • Extensive coverage of the Negative Pressure Wound Therapy (NPWT) under development.

  • Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.

  • Reviews of major players involved in the pipeline product development.

  • Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Negative Pressure Wound Therapy (NPWT) pipeline products.

  • Review of recent developments in the segment/industry.

Aatru Medical LLC
Acelity L.P. Inc.
Adept Medical Ltd
Aroa Biosurgery Ltd
Ceramatec Inc
CloSure Inc
ConvaTec Group Plc
DeRoyal Industries Inc
Healyx Labs Inc
Invacare Corporation
Ion-Vac Inc
MEDICUD Srl
MLM Biologics Inc
Montana State University
Nexgel Inc
Otivio AS
Progenerative Medical Inc
ReHeal LLC
Rmmedi Innovations Pvt Ltd
S2Medical AB
Shieldheart Medtech AB
Smith & Nephew Medical Ltd
Smith & Nephew Plc
UMass Chan Medical School
University of Pisa
Wake Forest Baptist Medical Center
Worldwide Innovative Healthcare, Inc.

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 8

2 Introduction 9

2.1 Negative Pressure Wound Therapy (NPWT) Overview 9

3 Products under Development 10

3.1 Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Stage of Development 10

3.2 Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Segment 11

3.3 Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Territory 12

3.4 Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Regulatory Path 13

3.5 Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Estimated Approval Date 14

3.6 Negative Pressure Wound Therapy (NPWT) – Ongoing Clinical Trials 15

4 Negative Pressure Wound Therapy (NPWT) – Pipeline Products under Development by Companies 16

4.1 Negative Pressure Wound Therapy (NPWT) Companies – Pipeline Products by Stage of Development 16

4.2 Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Stage of Development 18

5 Negative Pressure Wound Therapy (NPWT) Companies and Product Overview 19

5.1 Aatru Medical LLC Company Overview 19

5.1.1 Aatru Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 19

5.2 Acelity L.P. Inc. Company Overview 22

5.2.1 Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 Adept Medical Ltd Company Overview 23

5.3.1 Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 Aroa Biosurgery Ltd Company Overview 24

5.4.1 Aroa Biosurgery Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

5.5 Ceramatec Inc Company Overview 26

5.5.1 Ceramatec Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.6 CloSure Inc Company Overview 27

5.6.1 CloSure Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.7 ConvaTec Group Plc Company Overview 28

5.7.1 ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 28

5.8 DeRoyal Industries Inc Company Overview 29

5.8.1 DeRoyal Industries Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.9 Healyx Labs Inc Company Overview 32

5.9.1 Healyx Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.10 Invacare Corporation Company Overview 33

5.10.1 Invacare Corporation Pipeline Products & Ongoing Clinical Trials Overview 33

5.11 Ion-Vac Inc Company Overview 34

5.11.1 Ion-Vac Inc Pipeline Products & Ongoing Clinical Trials Overview 34

5.12 MEDICUD Srl Company Overview 35

5.12.1 MEDICUD Srl Pipeline Products & Ongoing Clinical Trials Overview 35

5.13 MLM Biologics Inc Company Overview 37

5.13.1 MLM Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.14 Montana State University Company Overview 38

5.14.1 Montana State University Pipeline Products & Ongoing Clinical Trials Overview 38

5.15 Nexgel Inc Company Overview 39

5.15.1 Nexgel Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.16 Otivio AS Company Overview 40

5.16.1 Otivio AS Pipeline Products & Ongoing Clinical Trials Overview 40

5.17 Progenerative Medical Inc Company Overview 44

5.17.1 Progenerative Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.18 ReHeal LLC Company Overview 45

5.18.1 ReHeal LLC Pipeline Products & Ongoing Clinical Trials Overview 45

5.19 Rmmedi Innovations Pvt Ltd Company Overview 46

5.19.1 Rmmedi Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

5.20 S2Medical AB Company Overview 48

5.20.1 S2Medical AB Pipeline Products & Ongoing Clinical Trials Overview 48

5.21 Shieldheart Medtech AB Company Overview 49

5.21.1 Shieldheart Medtech AB Pipeline Products & Ongoing Clinical Trials Overview 49

5.22 Smith & Nephew Medical Ltd Company Overview 50

5.22.1 Smith & Nephew Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

5.23 Smith & Nephew Plc Company Overview 51

5.23.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 51

5.24 UMass Chan Medical School Company Overview 53

5.24.1 UMass Chan Medical School Pipeline Products & Ongoing Clinical Trials Overview 53

5.25 University of Pisa Company Overview 54

5.25.1 University of Pisa Pipeline Products & Ongoing Clinical Trials Overview 54

5.26 Wake Forest Baptist Medical Center Company Overview 55

5.26.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 55

5.27 Worldwide Innovative Healthcare, Inc. Company Overview 56

5.27.1 Worldwide Innovative Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56

6 Negative Pressure Wound Therapy (NPWT)- Recent Developments 57

6.1 Jul 11, 2023: Invacare Holdings Names Kai Zhu Senior VP, CFO 57

6.2 May 04, 2023: Cardinal Health reports third quarter fiscal year 2023 results and raises fiscal year 2023 non-gaap eps guidance 57

6.3 Apr 26, 2023: Smith & Nephew announces Q1 2023 trading update 59

6.4 Apr 06, 2023: Smith & Nephew Notice of First Quarter 2023 Trading Report 61

6.5 Mar 06, 2023: Smith & Nephew Announces Annual Financial Report 2022 61

6.6 Mar 06, 2023: Smith & Nephew Notice of 2023 Annual General Meeting 62

6.7 Feb 21, 2023: Smith & Nephew Announces Fourth Quarter and Full Year 2022 Results 62

6.8 Feb 19, 2023: Daewoong Pharmaceutical Reaches Sales of KRW

1.16 Trillion in 2022 Fexuclue Leads The Highest Revenue 63

6.9 Feb 02, 2023: Cardinal Health Reports Second Quarter Fiscal Year 2023 Results and Raises Fiscal Year 2023 Non-GAAP EPS Guidance 64

6.10 Dec 19, 2022: Cardinal Health Names Aaron Alt Chief Financial Officer 66

6.11 Nov 21, 2022: Invacare Appoints Geoff Purtill President and Chief Executive Officer 66

6.12 Nov 15, 2022: Daewoong Pharmaceutical Surpasses KRW 300 Billion in Q3 Revenue as Nabota Sales Grew by 93%, Leading Overall Growth in Revenue 67

6.13 Nov 11, 2022: France Bed Holdings Consolidated Financial Results for the Six Months Ended September 30, 2022 68

6.14 Nov 07, 2022: Invacare Reports Results for Third Quarter 2022 69

7 Appendix 72

7.1 Methodology 72

7.2 About GlobalData 75

7.3 Contact Us 75

7.4 Disclaimer 75

Table

Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Stage of Development 10

Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Segment 11

Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Territory 12

Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Regulatory Path 13

Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Estimated Approval Date 14

Negative Pressure Wound Therapy (NPWT) – Ongoing Clinical Trials 15

Negative Pressure Wound Therapy (NPWT) Companies – Pipeline Products by Stage of Development 16

Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Stage of Development 18

Aatru Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 19

NpSIMS Negative Pressure Surgical Incision Management System – Product Status 19

NpSIMS Negative Pressure Surgical Incision Management System – Product Description 19

Aatru Medical LLC – Ongoing Clinical Trials Overview 20

NpSIMS Negative Pressure Surgical Incision Management System – A Clinical Evaluation of a Novel, Single-use, Negative Pressure Wound Therapy (NPWT) System for the Management of Closed Surgical Wounds 21

Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

Negative Pressure Regenerative Medicine – Hard Tissue – Product Status 22

Negative Pressure Regenerative Medicine – Hard Tissue – Product Description 22

Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Wound Pressure Device – Product Status 23

Wound Pressure Device – Product Description 23

Aroa Biosurgery Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

AROA ECM Sleeve – Product Status 24

AROA ECM Sleeve – Product Description 24

Endoform – NPWT Device – Product Status 25

Endoform – NPWT Device – Product Description 25

Ceramatec Inc Pipeline Products & Ongoing Clinical Trials Overview 26

OsmoHeal System – Product Status 26

OsmoHeal System – Product Description 26

CloSure Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Negative Pressure Wound Therapy Device – Product Status 27

Negative Pressure Wound Therapy Device – Product Description 27

ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 28

Avelle 2.0 – Product Status 28

Avelle 2.0 – Product Description 28

DeRoyal Industries Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Prospera Flex Incisional NPWT System – Product Status 29

Prospera Flex Incisional NPWT System – Product Description 29

DeRoyal Industries Inc – Ongoing Clinical Trials Overview 30

Prospera Flex Incisional NPWT System – Healthy Human Study on DeRoyal Incisional Dressing With NPWT Compared Against Standard of Care NPWT Incision Dressing to Investigate Bioburden Levels and Skin Condition After Seven Day Period 31

Healyx Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Kyron NPWT System – Product Status 32

Kyron NPWT System – Product Description 32

Invacare Corporation Pipeline Products & Ongoing Clinical Trials Overview 33

Negative-Pressure Wound Therapy System – Product Status 33

Negative-Pressure Wound Therapy System – Product Description 33

Ion-Vac Inc Pipeline Products & Ongoing Clinical Trials Overview 34

Chronic Wound Therapy System – Product Status 34

Chronic Wound Therapy System – Product Description 34

MEDICUD Srl Pipeline Products & Ongoing Clinical Trials Overview 35

Negative Incisional Pressure Therapy Device – Product Status 35

Negative Incisional Pressure Therapy Device – Product Description 35

Negative Pressure Dressing Device – Product Status 36

Negative Pressure Dressing Device – Product Description 36

MLM Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Wound Matrix – Negative Pressure Wound Therapy – Product Status 37

Wound Matrix – Negative Pressure Wound Therapy – Product Description 37

Montana State University Pipeline Products & Ongoing Clinical Trials Overview 38

Tissue Cooling Negative Pressure Wound Therapy System – Product Status 38

Tissue Cooling Negative Pressure Wound Therapy System – Product Description 38

Nexgel Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Negative Pressure Device – Product Status 39

Negative Pressure Device – Product Description 39

Otivio AS Pipeline Products & Ongoing Clinical Trials Overview 40

Flowox – Connectivity Version – Product Status 40

Flowox – Connectivity Version – Product Description 40

FlowOx 2.0 – Multiple Sclerosis – Product Status 41

FlowOx 2.0 – Multiple Sclerosis – Product Description 41

Otivio AS – Ongoing Clinical Trials Overview 42

FlowOx 2.0 – Multiple Sclerosis – A Double-blind, Randomized, Controlled, Parallel Design 4-week Investigation, Followed by an Open 6-month Investigation, to Evaluate the Performance and Long-term Safety of FlowOx2.0 in Patients with Multiple Sclerosis 43

FlowOx 2.0 – Multiple Sclerosis – An Open 6-month Investigation, to Evaluate the Performance and Long-term Safety of FlowOx2.0 in Subjects with Multiple Sclerosis 43

Progenerative Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Regenn Therapy Device – Product Status 44

Regenn Therapy Device – Product Description 44

ReHeal LLC Pipeline Products & Ongoing Clinical Trials Overview 45

REHEAL Glove – Product Status 45

REHEAL Glove – Product Description 45

Rmmedi Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

HUG – Product Status 46

HUG – Product Description 46

PEQUE – Product Status 47

PEQUE – Product Description 47

S2Medical AB Pipeline Products & Ongoing Clinical Trials Overview 48

ivaQ – Product Status 48

ivaQ – Product Description 48

Shieldheart Medtech AB Pipeline Products & Ongoing Clinical Trials Overview 49

ShieldHeart Protection Device – Product Status 49

ShieldHeart Protection Device – Product Description 49

Smith & Nephew Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

Renasys Edge (66803126) – Product Status 50

Renasys Edge (66803126) – Product Description 50

Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 51

Next-Gen NPWT – Product Status 51

Next-Gen NPWT – Product Description 51

Next-Generation PICO – Product Status 52

Next-Generation PICO – Product Description 52

Next-Generation Renasys – Product Status 52

Next-Generation Renasys – Product Description 52

UMass Chan Medical School Pipeline Products & Ongoing Clinical Trials Overview 53

Negative Pressure Amputation Wound Closure Device – Product Status 53

Negative Pressure Amputation Wound Closure Device – Product Description 53

University of Pisa Pipeline Products & Ongoing Clinical Trials Overview 54

Smart Wearable And Autonomous Negative Pressure Device – Product Status 54

Smart Wearable And Autonomous Negative Pressure Device – Product Description 54

Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 55

Mechanical Tissue Resuscitation Device – Product Status 55

Mechanical Tissue Resuscitation Device – Product Description 55

Worldwide Innovative Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56

Wound-Pump – Product Status 56

Wound-Pump – Product Description 56

Glossary 74

Figures

Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Stage of Development 10

Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Segment 11

Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Territory 12

Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Regulatory Path 13

Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Estimated Approval Date 14

Negative Pressure Wound Therapy (NPWT) – Ongoing Clinical Trials 15

Frequently asked questions

Negative Pressure Wound Therapy (NPWT) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Negative Pressure Wound Therapy (NPWT) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Negative Pressure Wound Therapy (NPWT) reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Negative Pressure Wound Therapy (NPWT) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Negative Pressure Wound Therapy (NPWT) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more